Transcription
The transcript length is 4338 bp. An alternatively spliced variant has been reported with a transcript length of 5655 bp.
Pseudogene
No pseudogenes have been reported.
Protein

Description
Amino acids: 1445. Molecular weight: 162058 Daltons. The PTPRG gene belongs to the receptor class 5 subfamily of the protein-tyrosine phosphatase family.
Expression
PTPRG is expressed in several tissues.
Localisation
Membrane. Single-pass type I membrane protein.
Function
Involved in regulating signaling through ligandcontrolled protein tyrosine dephosphorylation. The protein contains an extracellular carbonic anhydraselike and fibronectin type III-like domain, a single transmembrane domain, and a cytoplasmic region with 2 tandem catalytic tyrosine phosphatase domains. Y2H, animal models.
Homology
PTPRG shares a PTP domain, involved in dephosphorylating phosphorylated tyrosine residues, with the other receptor-like protein tyrosine phosphatases. The PTPRG gene is conserved in vertebrates. The human and mouse (1442-amino acid) sequences share 95% identity at the amino acid level.
Mutations
Germinal
No germline mutations have been reported. Somatic 8 different missense mutations in the PTPRG gene have been identified in colon carcinomas: C1082T (T361M), C1385T (A462V), C1541T (T514M), C1777T (R593W), A2864G (E955G), A2918G (Y973C), C3934T (R1312W) A3976G (I1326V). Loss of heterozygosity (LOH) of a region which includes the PTPRG locus has been shown in clear renal cell carcinoma, lung carcinoma and colon carcinoma.
Implicated in
Note: PTPRG has been considered a potential tumor suppressor gene based on its function, antagonizing activity of protein tyrosine kinases that often function as oncoproteins. Secondly, because it maps to a region of human chromosome 3, 3p21, that is frequently deleted in renal cell carcinoma and Lung carcinoma. Thirdly, because PTPRG has been shown to harbor point mutations in a subset of colon carcinomas. Fourthly, because the PTPRG gene shows promoter hypermethylation in cutaneous T-cell lymphoma and melanoma. Finally, lower expression levels of PTPRG have been reported for a number of cancerous tissues including gastric cancer.
